VL
AQST icon

Vima LLC’s Aquestive Therapeutics AQST Stock Holding History

Vima LLC’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5K Buy
+600
New +$2.52K ﹤0.01% 334

Other funds holding AQST

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
EAM
Everstar Asset Management Mooresville, North Carolina $207M AUM 18.14% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SMAM
Sugar Maple Asset Management Sister Bay, Wisconsin $155M AUM 17.72% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return

Vima LLC's AQST Position: Q2 2026 in Review

Vima LLC opened a new position in Aquestive Therapeutics (AQST) in Q2 2026: 600 shares worth $2.5K. The stake represents ﹤0.01% of the portfolio and ranks #334 among its holdings.

38 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Vima LLC held 600 shares of Aquestive Therapeutics worth $2.5K as of Q2 2026.
  • Aquestive Therapeutics was a new Vima LLC position in Q2 2026.
  • Aquestive Therapeutics made up ﹤0.01% of Vima LLC's portfolio in Q2 2026, its #334 holding.
  • 38 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Vima LLC's 13F filing for Q2 2026, filed 24 Jul 2026.